<SEC-DOCUMENT>0001193125-19-272080-index.html : 20191023 <SEC-HEADER>0001193125-19-272080.hdr.sgml : 20191023 <ACCEPTANCE-DATETIME>20191023073039 ACCESSION NUMBER: 0001193125-19-272080 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20191021 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20191023 DATE AS OF CHANGE: 20191023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 191162657 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-207-0202 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>d821648d8k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: d821648d8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>d821648dex101.htm <DESCRIPTION>EX-10.1 <TEXT> Document 2 - file: d821648dex101.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>3 <FILENAME>d821648dex102.htm <DESCRIPTION>EX-10.2 <TEXT> Document 3 - file: d821648dex102.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>d821648dex991.htm <DESCRIPTION>EX-99.1 <TEXT> Document 4 - file: d821648dex991.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g821648g1022203850773.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g821648g1022203850773.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g821648g19c01.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g821648g19c01.jpg
</DOCUMENT> </SEC-DOCUMENT>